Oliclinomel N5-800e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Oliclinomel N5-800e is used in the context of parenteral nutrition and amino acid supplementation for patients who cannot take food orally.

• Parenteral nutrition: supports protein synthesis and metabolic needs when enteral feeding is not possible.
• Amino acid supplementation: restores essential amino acid levels in patients with prolonged fasting or malnutrition.
• Critical illness: helps maintain nitrogen balance and muscle mass in critically ill patients.

• The solution delivers a balanced mixture of essential amino acids directly into the bloodstream, bypassing the gastrointestinal tract. These amino acids become substrates for protein synthesis, replenish depleted intracellular pools, support nitrogen balance, and provide precursors for metabolic pathways essential for cellular function during parenteral nutrition.

Adverse reactions may occur with intravenous amino acid solutions. Monitoring and prompt management are recommended.

Common Side Effects

• Mild hyperglycemia: transient elevation of blood glucose levels.
• Electrolyte disturbances: temporary shifts in potassium, sodium, or calcium.
• Infusion site erythema: redness or irritation at the catheter site.
• Nausea: mild gastrointestinal discomfort.
• Headache: transient headache during or after infusion.
• Taste alteration: temporary metallic taste.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate intervention.
• Severe hyperosmolarity: excessive osmotic load leading to neurologic symptoms.
• Metabolic acidosis: significant drop in blood pH.
• Hepatic dysfunction: abnormal liver enzyme elevations.
• Renal impairment: worsening kidney function in susceptible patients.
• Severe electrolyte imbalance: life‑threatening potassium or calcium shifts.

When using Oliclinomel N5-800e, clinicians should observe several safety measures.

• Renal function assessment: evaluate baseline kidney status before infusion.
• Blood glucose monitoring: check glucose levels regularly, especially in diabetic patients.
• Electrolyte monitoring: track serum electrolytes during therapy.
• Aseptic technique: ensure sterile handling of the infusion set.
• Dose adjustment in hepatic impairment: modify infusion rates if liver function is compromised.
• Hypersensitivity screening: avoid use in patients with known allergy to any amino acid component.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Amino acid infusions can interact with other therapies; awareness helps prevent complications.

Major Interactions (Avoid)

• High‑dose glucose solutions: may exacerbate hyperglycemia.
• Nephrotoxic drugs (e.g., aminoglycosides): increase renal load and risk of injury.
• Large electrolyte supplements: can cause dangerous electrolyte overload.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may amplify electrolyte shifts.
• Corticosteroids: can affect protein catabolism and nitrogen balance.
• Insulin therapy: requires tighter glucose monitoring.
• Other parenteral nutrition components: adjust concentrations to avoid incompatibility.
• Anticoagulants: monitor clotting parameters as amino acids may influence platelet function.